CDMO Archives - Express Pharma

OneSource pharma launches new brand identity at CPHI, Milan

Advantage India due to the Biosecure Act

Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Suven to acquire controlling stake in Sapala Organics, a CDMO player

M&A trends to watch out in pharma

Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData

Pharma, healthcare sector attract investment despite volume dip in Q3 2023: Report

Enzene Biosciences inaugurates R&D Center with open lab setup in Pune

JB Pharma: Betting big on India

Baxter to divest biopharma solutions business to Advent International and Warburg Pincus for $4.25 bn